Discover NeuroOne's record-breaking Q4 2025 earnings, major product launches, and strategic partnership growth in pain management and drug delivery.

Aptar Group, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, ...

Researchers in the Nanoscience Center at the University of Jyväskylä, Finland, have developed a pioneering computational ...

Aptar Group said its intranasal medical delivery technology will be used to administer Cardamyst, a treatment for paroxysmal supraventricular tachycardia in adults.

A generalizable ML framework predicts protein interactions with ligand-stabilized gold nanoclusters, supporting faster design ...

The Hong Kong Polytechnic University (PolyU) has developed an acid-resistant "ultra-stable mucus-inspired hydrogel" (UMIH), ...

InnoCan Pharma ( ($TSE:INNO) ) has provided an announcement. Innocan Pharma announced promising preliminary findings regarding its liposomal ...

Insightec, a global healthcare innovator pioneering the use of focused ultrasound to transform patient care, today announced ...

First Patient Dosed with Intranasal Foralumab in Randomized, Placebo-Controlled Phase 2 TrialBuilds on Recent Evidence of Persistent Neuroinflammation in Alzheimer’s Patients Treated with Anti-Amyloid ...

First Patient Dosed with Intranasal Foralumab in Randomized, Placebo-Controlled Phase 2 TrialBuilds on Recent Evidence of Persistent Neuroinflammation in Alzheimer's Patients Treated with Anti-Amyloid ...

The U.S. Postal Service said Wednesday it intends to open its “last-mile” delivery network, the most expensive part of the ...

Animal welfare is increasingly recognized as a core dimension of veterinary medicine, extending beyond the absence of disease to encompass the management of ...